Relative Bioavailability of Once-Daily Clonidine XR Oral Suspension Versus Twice-Daily XR Tablets in Healthy Volunteers
Journal of Attention Disorders: A Journal of Theoretical and Applied Science
Published online on July 27, 2026
Abstract
Journal of Attention Disorders, Ahead of Print.
Purpose:To assess the bioequivalence of once-daily clonidine extended-release (XR) oral suspension (OS) to twice-daily clonidine XR tablets (TABs), which are approved for attention-deficit/hyperactivity disorder (ADHD).Methods:Study 1 (n= 20) evaluated ...
Purpose:To assess the bioequivalence of once-daily clonidine extended-release (XR) oral suspension (OS) to twice-daily clonidine XR tablets (TABs), which are approved for attention-deficit/hyperactivity disorder (ADHD).Methods:Study 1 (n= 20) evaluated ...